NAVAMEDIC (NAVA.OL) Stock Price, Quote, News and Overview
OSL:NAVA - Euronext Oslo - NO0010205966 - Common Stock - Currency: NOK
NAVA.OL Quote, Performance and Key Statistics
OSL:NAVA (4/25/2025, 7:00:00 PM)
21.3
+0.3 (+1.43%)
The current stock price of NAVA.OL is 21.3 NOK. In the past month the price decreased by -6.58%. In the past year, price decreased by -37.35%.
NAVA.OL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY.DE | ELI LILLY & CO | 66.68 | 722.56B | ||
| 1LLY.MI | ELI LILLY & CO | 65.4 | 708.62B | ||
| ZEG.DE | ASTRAZENECA PLC | 16.88 | 377.93B | ||
| JNJ.DE | JOHNSON & JOHNSON | 15.27 | 324.94B | ||
| NOV.DE | NOVO NORDISK A/S-B | 17.94 | 241.31B | ||
| SNW.DE | SANOFI | 12.07 | 226.94B | ||
| SAN.PA | SANOFI | 13.72 | 226.10B | ||
| 6MK.DE | MERCK & CO. INC. | 10.34 | 174.89B | ||
| 1MRKX.MI | MERCK & CO. INC. | 10.16 | 171.87B | ||
| PFE.DE | PFIZER INC | 7.36 | 113.97B | ||
| 1PFE.MI | PFIZER INC | 7.17 | 111.02B | ||
| BRM.DE | BRISTOL-MYERS SQUIBB CO | 41.5 | 84.44B |
Related stock screener links
About NAVA.OL
Company Profile
Navamedic ASA engages in the delivery and marketing of pharmaceutical products to patients, hospitals, and pharmacies. The company is headquartered in Oslo, Oslo and currently employs 45 full-time employees. The company went IPO on 2006-03-31. The company is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The firm has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The firm has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Company Info
NAVAMEDIC
Henrik Ibsens gate 100
Oslo OSLO NO
Employees: 45
Company Website: https://navamedic.com/
Investor Relations: http://navamedic.com/investors
Phone: 4767112540
NAVAMEDIC / NAVA.OL FAQ
What is the stock price of NAVAMEDIC today?
The current stock price of NAVA.OL is 21.3 NOK. The price increased by 1.43% in the last trading session.
What is the ticker symbol for NAVAMEDIC stock?
The exchange symbol of NAVAMEDIC is NAVA and it is listed on the Euronext Oslo exchange.
On which exchange is NAVA.OL stock listed?
NAVA.OL stock is listed on the Euronext Oslo exchange.
What is the price forecast or stock price prediction for NAVAMEDIC stock?
8 analysts have analysed NAVA.OL and the average price target is 34.68 NOK. This implies a price increase of 62.82% is expected in the next year compared to the current price of 21.3. Check the NAVAMEDIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NAVAMEDIC worth?
NAVAMEDIC (NAVA.OL) has a market capitalization of 376.16M NOK. This makes NAVA.OL a Small Cap stock.
How many employees does NAVAMEDIC have?
NAVAMEDIC (NAVA.OL) currently has 45 employees.
What are the support and resistance levels for NAVAMEDIC (NAVA.OL) stock?
NAVAMEDIC (NAVA.OL) has a support level at 21.16 and a resistance level at 21.9. Check the full technical report for a detailed analysis of NAVA.OL support and resistance levels.
Is NAVAMEDIC (NAVA.OL) expected to grow?
The Revenue of NAVAMEDIC (NAVA.OL) is expected to grow by 10.85% in the next year. Check the estimates tab for more information on the NAVA.OL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NAVAMEDIC (NAVA.OL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NAVA.OL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NAVA.OL, evaluating the profitability, health, valuation and growth aspects
- NAVAMEDIC (NAVA.OL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NAVAMEDIC (NAVA.OL) Sales and EPS estimates to see what analysts future expectations are.
- NAVAMEDIC (NAVA.OL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NAVAMEDIC (NAVA.OL) Insider and Institutional Ownership to learn about the owners and their transactions.
- NAVAMEDIC (NAVA.OL) Stock Chart to make your own analysis
- NAVAMEDIC (NAVA.OL) Latest news and press-releases to stay up to date.
Does NAVAMEDIC (NAVA.OL) stock pay dividends?
NAVA.OL does not pay a dividend.
What is the Price/Earnings (PE) ratio of NAVAMEDIC (NAVA.OL)?
The PE ratio for NAVAMEDIC (NAVA.OL) is 304.29. This is based on the reported non-GAAP earnings per share of 0.07 and the current share price of 21.3 NOK. Check the full fundamental report for a full analysis of the valuation metrics for NAVA.OL.
NAVA.OL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to NAVA.OL. When comparing the yearly performance of all stocks, NAVA.OL is a bad performer in the overall market: 88.64% of all stocks are doing better.
NAVA.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NAVA.OL. NAVA.OL has a bad profitability rating. Also its financial health evaluation is rather negative.
NAVA.OL Financial Highlights
Over the last trailing twelve months NAVA.OL reported a non-GAAP Earnings per Share(EPS) of 0.07. The EPS decreased by -62.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.24% | ||
| ROA | 0.26% | ||
| ROE | 0.54% | ||
| Debt/Equity | 0.33 |
NAVA.OL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to NAVA.OL. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -43.8% and a revenue growth 10.85% for NAVA.OL